As the first company to file an application to produce a Gleevec generic in the US, Mumbai-based Sun Pharmaceutical Industries Ltd. gained six months of marketing exclusivity – which ended this month.
Now two generic competitors have entered the market with their own versions and more are expected. This will add to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?